SunTrust Banks, Inc. began coverage on shares of PETIQ INC (NASDAQ:PETQ) in a report issued on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $28.00 price objective on the stock. SunTrust Banks also issued estimates for PETIQ INC’s Q3 2017 earnings at $0.10 EPS, Q4 2017 earnings at $0.06 EPS, FY2017 earnings at $0.67 EPS, Q1 2018 earnings at $0.19 EPS, Q2 2018 earnings at $0.29 EPS, Q3 2018 earnings at $0.18 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.80 EPS and FY2019 earnings at $1.03 EPS.
A number of other research firms also recently commented on PETQ. William Blair began coverage on PETIQ INC in a report on Tuesday. They set an outperform rating for the company. Jefferies Group LLC began coverage on PETIQ INC in a report on Tuesday. They set a hold rating and a $25.00 price objective for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $27.00.
PETIQ INC (NASDAQ PETQ) opened at 22.60 on Tuesday. The stock’s 50 day moving average price is $27.27 and its 200 day moving average price is $27.27. The stock’s market capitalization is $277.64 million. PETIQ INC has a 52-week low of $19.76 and a 52-week high of $25.44.
PETIQ INC Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PETIQ INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PETIQ INC and related companies with MarketBeat.com's FREE daily email newsletter.